Duvaxyn EHV 1.4

For vaccination against Equine Herpesvirus caused by EHV1 and EHV4

Duvaxyn® EHV 1,4 Vaccine

• 
  
  Inactivated herpesvirus vaccine for use in horses.
  

   

Recommendations for Use

• 
  
  For the vaccination of healthy horses and ponies for reduction in the clinical signs of the respiratory diseases caused by EHV-1 and EHV-4.


• 
  
  For use as an aid in the control of EHV-1 abortion when used in conjunction with appropriate management practices. Pregnant mares vaccinated with this product may still abort.


• 
  
  The vaccine is recommended for use in healthy horses and ponies from five months of age.

Clinical Use

Vaccination against respiratory disease

• 
  
  Primary course: A single dose of Duvaxyn EHV1,4 should be administered from five months of age followed by a second injection of Duvaxyn EHV1,4 after an interval of 4-6 weeks. In the event of increased infection risk, for example when a foal has consumed insufficient colostrum or there is risk of early exposure to field infections with EHV-1 or EHV-4, an earlier vaccination may be given. In these circumstances the foal should receive a single dose of Duvaxyn EHV1,4 from three months of age followed by the above mentioned full primary vaccination course.
  

   



• 
  
  Boosting immunity: Following completion of the primary course, a single dose of Duvaxyn EHV1,4 should be administered every six months.
  

   

Vaccination to aid in the control of abortion

• 
  
  For use as an aid in the control of EHV-1 abortion when used in conjunction with appropriate management practices. (Pregnant mares that have been previously primed should be vaccinated during the 5th, 7th and 9th months of pregnancy with a single dose on each occasion). Infected, pregnant mares vaccinated with this product may still abort.